INS and type 2 diabetes mellitus: When dietary measures and oral glucose lowering drugs (OGLDs) fail to sufficiently correct glucose dysregulation, most treatment guidelines for type 2 diabetes (T2DM) advise to start or add either an injectable glucagon‐like peptide‐1 analogue or insulin therapy.1